Ronil A. Patel - Apr 24, 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role
SVP, Operations & Bus. Dev.
Signature
/s/ Emily J. Johns, by Power of Attorney
Stock symbol
OCUP
Transactions as of
Apr 24, 2023
Transactions value $
$0
Form type
4
Date filed
4/26/2023, 09:25 PM
Next filing
Dec 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Award $0 +20K +89.67% $0.00 42.3K Apr 24, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Employee Stock Option (right to buy) Award $0 +30K $0.00 30K Apr 24, 2023 Common Stock 30K $5.35 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of April 24, 2023.
F2 The option will vest with respect to 7,500 shares on April 24, 2024, with the balance vesting quarterly in twelve equal installments thereafter.